The addition of anti-IL-27 neutralizing antibody inhibited B-cell dysfunction, indicating that IL-27 may promote peripheral B-cell dysfunction in patients with RA by activating mTOR signaling (123). The gene discussed is MTOR; the disease is rheumatoid arthritis.